MARVF yields 71428.57% · JNJ yields 3.36%● Live data
📍 MARVF pulled ahead of the other in Year 1
Combined, MARVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MARVF + JNJ for your $10,000?
Marvel Discovery Corp. engages in the acquisition, exploration, and development of mineral properties in Canada. The company has an option to acquire a 100% interest in the Duhamel Property consists of nine mineral claims covering an area of approximately 500 hectares located northwest of the city of the Saguenay, Quebec; the Wicheeda North project comprises 18 claims that covers 4,423.8 hectares situated Northeast of Prince George, British Columbia; and the Blackfly property that includes five claims consisting of 64 unpatented mining claims located in Atikokan, Ontario. It also has an option to acquire a 100% interest in Slip Gold property consists of six claims with 264 claim units situated in Newfoundland; the Victoria/Long Lake comprises five claims with 53 claim units located in Newfoundland; the East Bull property, which includes 16 mineral claims situated in the Deagle, Gaiashk, and Gerow mining district, Ontario; and the Sandy Pond and Baie Verte Line property comprising 335 mineral claims located in the Province of Newfoundland and Labrador, as well as holds interest in Gander South project comprises 14 mineral claims situated in Newfoundland. In addition, Marvel Discovery Corp. has an option to acquire a 100% interest in the Highway North property consists of five contiguous claims totaling 2,573 hectares located in the Athabasca region of Saskatchewan. The company was formerly known as International Montoro Resources Inc. and changed its name to Marvel Discovery Corp. in February 2021. Marvel Discovery Corp. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Full MARVF Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.